Collaborative Drug Development
The landscape of drug development in aging biology is surprisingly collaborative, with various companies targeting distinct molecular pathways rather than competing directly against one another. This unique ecosystem fosters innovation, as multiple approaches to cellular dysfunction emerge, paving the way for breakthroughs in health span extension. Once the first drug is approved for this purpose, it will set a precedent that benefits the entire field, much like the evolution seen with statins.In this clip
From this podcast
Newcomer Podcast
Life Extension Innovations, Moonshots & Snake Oil (with Celine Halioua & James Peyer)
Related Questions